Jury Finds Arm Breached Its Qualcomm License and Sought to Disrupt Its Business, Awards $2

A Delaware jury on Tuesday found that Arm Holdings breached its architectural license agreement with Qualcomm and intentionally sought to disrupt Qualcomm's business, awarding the chipmaker $2 in nominal damages, according to a Qualcomm spokesperson.

The verdict closes a five-day federal trial in Wilmington, Delaware — the second courtroom fight between the two companies in two years — and it lands against the licensor on the central question Qualcomm put to the jury: whether Arm broke the promises in the long-standing architectural license agreement (ALA) that Qualcomm's entire chip business is built on. Arm did not immediately respond to a request for comment, and its shares were down more than 1% in afternoon trading after the verdict.

Two dollars is the point, not the prize

Nominal damages are what a jury awards when it finds a wrong occurred but no large, proven financial loss follows from it. That split is the honest shape of this result. Qualcomm won the finding — a breach of the ALA, and conduct the jury characterised as an intentional effort to disrupt its business. Arm won the arithmetic: it had argued throughout the trial that Qualcomm was not harmed in the least, and a $2 award says the jury did not price the proven harm anywhere near the scale Qualcomm's rhetoric implied.

Investors should therefore not model $2. They should model what the breach finding unlocks, because Qualcomm built this lawsuit around a contract clause, not around a damages number.

What Qualcomm accused Arm of doing

Qualcomm asked the jury to find that Arm breached its licensing agreements by withholding software patches and tools for its chip designs, and by violating an agreement meant to ensure Qualcomm paid within 10% of the lowest price for Arm's processor designs. It also asked the jury to find that Arm tried to torpedo Qualcomm's dealings with Meta Platforms by leaking to Bloomberg a 2024 Arm letter notifying Qualcomm that it was allegedly in breach of a key license agreement.

The trial hinged on many of the same episodes as the 2024 trial, in which Arm failed to convince a jury that Qualcomm had breached its license. Both chief executives testified — Arm's Rene Haas and Qualcomm's Cristiano Amon — before U.S. District Judge Maryellen Noreika. Qualcomm's counsel told the jury the case was serious because Qualcomm's entire chip business depends on Arm honouring its contract; Arm's counsel answered that Qualcomm suffered no harm and was using the suit as leverage in a fight over licensing terms.

The ruling that could actually move money

Before the trial, Qualcomm asked Judge Noreika to rule that a clause in the licensing agreements means it can stop paying royalties for five years if the contract is breached. She has not issued that ruling, and Arm has argued the royalty penalty is unenforceable. The jury has now supplied the predicate that request needed: a proven breach. Whether the clause survives, and what a five-year suspension would be worth, are questions for the judge, not the jury.

The scale is asymmetric. Qualcomm accounted for about 9% of Arm's revenue in the fiscal year ended March 31, 2026 — roughly $443 million of Arm's $4.92 billion, including license fees as well as royalties, according to Arm's annual filing. A multi-year royalty suspension would land on Arm's income statement far harder than the same dollars would register for Qualcomm, which is precisely why Arm has fought the clause as unenforceable rather than treating this as a $2 case.

A related bench trial over whether Arm is negotiating in good faith over new licensing terms also took place last week, and a decision on that could come well after the jury's verdict. Qualcomm's license for Arm's computing architecture runs until 2033; what is being fought over is the terms on which it can agree to new versions of that architecture.

What remains unknown

What remains unknown is nearly everything that determines the financial ending: whether Judge Noreika enforces the five-year royalty-suspension clause now that a breach has been found, when she rules on the parallel good-faith bench trial, whether Arm seeks to overturn the verdict through post-trial motions, and whether the two companies — licensor and one of its largest customers, bound together until at least 2033 — use the verdict to settle the wider licensing fight instead. The jury has answered the conduct question. The contract question, the one with real money attached, is still open.